Bone resorption predicts for skeletal complications in metastatic bone disease
BROWN, J. E, THOMSON, C. S, ELLIS, S. P, GUTCHER, S. A, PUROHIT, O. P, COLEMAN, R. E
Published in British journal of cancer (01.12.2003)
Published in British journal of cancer (01.12.2003)
Get full text
Journal Article
Double-blind, randomised, placebo-controlled, dose-finding study of oral ibandronate in patients with metastatic bone disease
Coleman, R. E., Purohit, O. P., Black, C., Vinholes, J. J. F., Schlosser, K., Huss, H., Quinn, K. J., Kanis, J.
Published in Annals of oncology (01.03.1999)
Published in Annals of oncology (01.03.1999)
Get full text
Journal Article
High-dose intravenous pamidronate for metastatic bone pain
PUROHIT, O. P, ANTHONY, C, RADSTONE, C. R, OWEN, J, COLEMAN, R. E
Published in British journal of cancer (01.09.1994)
Published in British journal of cancer (01.09.1994)
Get full text
Journal Article
High dose pamidronate : Clinical and biochemical effects in metastatic bone Disease
Get full text
Conference Proceeding
Journal Article
Metabolic effects of pamidronate in patients with metastatic bone disease
VINHOLES, J, GUO, C.-Y, PUROHIT, O. P, EASTELL, R, COLEMAN, R. E
Published in British journal of cancer (01.05.1996)
Published in British journal of cancer (01.05.1996)
Get full text
Journal Article
A randomised phase II study of oral pamidronate for the treatment of bone metastases from breast cancer
Coleman, R.E, Houston, S, Purohit, O.P, Rubens, R.D, Kandra, A, Ford, J
Published in European journal of cancer (1990) (01.05.1998)
Published in European journal of cancer (1990) (01.05.1998)
Get full text
Journal Article
Review of Testing and Use of Adjuvant Trastuzumab across a Cancer Network — Are We Treating the Right Patients?
Coulson, S.G, Kumar, V.S, Manifold, I.M, Hatton, M.Q, Ramakrishnan, S, Dunn, K.S, Purohit, O.P, Bridgewater, C, Coleman, R.E
Published in Clinical oncology (Royal College of Radiologists (Great Britain)) (01.05.2010)
Published in Clinical oncology (Royal College of Radiologists (Great Britain)) (01.05.2010)
Get full text
Journal Article
Prevention of anastrozole induced bone loss with monthly oral ibandronate: Final 5 year results from the ARIBON trial
Lester, J.E, Dodwell, D, Brown, J.E, Purohit, O.P, Gutcher, S.A, Ellis, S.P, Thorpe, R, Horsman, J.M, Coleman, R.E
Published in Journal of bone oncology (01.09.2012)
Published in Journal of bone oncology (01.09.2012)
Get full text
Journal Article
The use of bone markers in a 6-week study to assess the efficacy of oral clodronate in patients with metastatic bone disease
Brown, J E, McCloskey, E V, Dewar, J A, Body, J J, Cameron, D A, Harnett, A N, Ruutu, M, Purohit, O P, Tähtelä, R, Coleman, R E
Published in Calcified tissue international (01.11.2007)
Published in Calcified tissue international (01.11.2007)
Get full text
Journal Article
Epirubicin/Vinorelbine Adjuvant Chemotherapy in Young Women with Breast Cancer is Associated with Preservation of Menstrual Function
Zekri, J.M, El-Helw, L.M, Purohit, O.P, Hatton, M.Q, Coleman, R.E
Published in Clinical oncology (Royal College of Radiologists (Great Britain)) (01.09.2008)
Published in Clinical oncology (Royal College of Radiologists (Great Britain)) (01.09.2008)
Get full text
Journal Article
Use of monthly oral ibandronate to prevent anastrozole-induced bone loss during adjuvant treatment for breast cancer: Two-year results from the ARIBON study
Lester, J., Dodwell, D., Purohit, O. P., Gutcher, S. A., Ellis, S. P., Thorpe, R., Horsman, J. M., Brown, J. E., Hannon, R. A., Coleman, R. E.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
Effect of monthly oral ibandronate on anastrozole-induced bone loss during adjuvant treatment for breast cancer: One-year results from the ARIBON study
Lester, J. E., Gutcher, S. A., Ellis, S. P., Thorpe, R., Horsman, J. M., Brown, J. E., Purohit, O. P., Dodwell, D., Coleman, R. E.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article
Can an annual infusion of zoledronic acid protect against cancer-treatment induced bone loss (CTIBL)?
Brown, J. E., Lester, J., Ellis, S., Gutcher, S., Turner, L., Purohit, O.-P., Hancock, B., Coleman, R.
Published in Journal of clinical oncology (01.06.2005)
Published in Journal of clinical oncology (01.06.2005)
Get full text
Journal Article